Literature DB >> 8058744

Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.

J M Louis1, N T Nashed, K D Parris, A R Kimmel, D M Jerina.   

Abstract

Upon renaturation, the polyprotein MBP-delta TF-Protease-delta Pol, consisting of HIV-1 protease and short native sequences from the trans-frame protein (delta TF) and the polymerase (delta Pol) fused to the maltose-binding protein (MBP) of Escherichia coli, undergoes autoprocessing to produce the mature protease in two steps. The initial step corresponds to cleavage of the N-terminal sequence to release the protein intermediate Protease-delta Pol, which has enzymatic activity comparable to that of the mature enzyme. Subsequently, the mature enzyme is formed by a slower cleavage at the C terminus. The rate of increase in enzymatic activity is identical to that of the appearance of MBP-delta TF and the disappearance of the MBP-delta TF-Protease-delta Pol. Initial rates are linearly dependent on the protein concentration, indicating that the N-terminal cleavage is first-order in protein concentration. The reaction is competitively inhibited by pepstatin A and has a pH rate profile similar to that of the mature enzyme. These results and molecular modeling studies are discussed in terms of a mechanism in which a dimeric full-length fusion protein must form prior to rate-limiting intramolecular cleavage of the N-terminal sequence that leads to an increase in enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058744      PMCID: PMC44526          DOI: 10.1073/pnas.91.17.7970

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Mechanism of intramolecular activation of pepsinogen. Evidence for an intermediate delta and the involvement of the active site of pepsin in the intramolecular activation of pepsinogen.

Authors:  J Marciniszyn; J S Huang; J A Hartsuck; J Tang
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

2.  Enzymic activities of two-chain pepsinogen, two-chain pepsin, and the amino-terminal lobe of pepsinogen.

Authors:  X L Lin; Y Z Lin; G Koelsch; A Gustchina; A Wlodawer; J Tang
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

Review 3.  Retroviral proteases: first glimpses at the anatomy of a processing machine.

Authors:  A M Skalka
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

4.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.

Authors:  M A Navia; P M Fitzgerald; B M McKeever; C T Leu; J C Heimbach; W K Herber; I S Sigal; P L Darke; J P Springer
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

5.  Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A.

Authors:  Y Satow; G H Cohen; E A Padlan; D R Davies
Journal:  J Mol Biol       Date:  1986-08-20       Impact factor: 5.469

6.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.

Authors:  A Wlodawer; M Miller; M Jaskólski; B K Sathyanarayana; E Baldwin; I T Weber; L M Selk; L Clawson; J Schneider; S B Kent
Journal:  Science       Date:  1989-08-11       Impact factor: 47.728

7.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

Authors:  P L Darke; R F Nutt; S F Brady; V M Garsky; T M Ciccarone; C T Leu; P K Lumma; R M Freidinger; D F Veber; I S Sigal
Journal:  Biochem Biophys Res Commun       Date:  1988-10-14       Impact factor: 3.575

8.  Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.

Authors:  D H Rich
Journal:  J Med Chem       Date:  1985-03       Impact factor: 7.446

9.  Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV.

Authors:  N T Nashed; J M Louis; J M Sayer; E M Wondrak; P T Mora; S Oroszlan; D M Jerina
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

10.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  42 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage.

Authors:  Steven C Pettit; Sergei Gulnik; Lori Everitt; Andrew H Kaplan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  The nature of the N-terminal amino acid residue of HIV-1 RNase H is critical for the stability of reverse transcriptase in viral particles.

Authors:  Guney Boso; Claes Örvell; Nikunj V Somia
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

4.  Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain.

Authors:  C T Wang; Y C Chou; C C Chiang
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.

Authors:  Yunfeng Tie; Peter I Boross; Yuan-Fang Wang; Laquasha Gaddis; Fengling Liu; Xianfeng Chen; Jozsef Tozser; Robert W Harrison; Irene T Weber
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

6.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

7.  The maturation of HIV-1 protease precursor studied by discrete molecular dynamics.

Authors:  Sachie Kimura; Martina Caldarini; Ricardo A Broglia; Nikolay V Dokholyan; Guido Tiana
Journal:  Proteins       Date:  2013-11-22

8.  Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.

Authors:  G Schatz; I Pichova; V M Vogt
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors:  Jane M Sayer; John M Louis
Journal:  Proteins       Date:  2009-05-15

10.  Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing.

Authors:  Liangqun Huang; Alyssa Hall; Chaoping Chen
Journal:  Retrovirology       Date:  2010-03-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.